Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05556954 · ClinicalTrials.gov registry record

Diabetic Foot Ulcers Microbiome and Pathogen Identification

A clinical trial, sponsored by University of Michigan.

Completed
Registry status
103
Enrollment target

NCT05556954 is a clinical trial that has completed, run by University of Michigan. The registered enrollment target is 103 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05556954 has completed, sponsored by University of Michigan.

COMPLETED
Registry status
103 participants
Enrollment target

Study Summary

This research is being done because people with diabetes have reduced healing capacity and prone to develop infections of foot wounds. This can be problematic because wounds that become infected may result in amputation and more severe complications. New evidence suggests that a better understanding of the microbiome of wounds (e.g., bacterial presence) may provide information about wound healing and provide an earlier opportunity to identify an individual who may be prone to develop diabetic foot infection in their wound. Therefore, the purpose of this study is to evaluate the role of the microbiome of the diabetic foot ulcer in development of infection and wound healing. Once the role of the microbiome is confirmed, progress towards the prevention and treatment of diabetic foot ulcers and complications may be possible.

Interventions

  • PROCEDURE Wound debridement

Trial Details

FieldValue
Enrollment Target 103 participants
Start Date 2022-10-13
Est. Completion 2025-06-04

Sponsor

University of Michigan

1,327 total trials

What the Registry Record Tells You About NCT05556954

The ClinicalTrials.gov registry entry for NCT05556954 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 103 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Wound debridement is the first listed.

NCT05556954 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT05556954 about?

NCT05556954 is a clinical study titled "Diabetic Foot Ulcers Microbiome and Pathogen Identification". This research is being done because people with diabetes have reduced healing capacity and prone to develop infections of foot wounds. This can be problematic because wounds that become infected may result in amputation and more severe complications. New evidence suggests that a better understanding...

What is the current status of trial NCT05556954?

This trial is currently completed. The enrollment target is 103 participants. The study started on 2022-10-13. Estimated completion is 2025-06-04.

What interventions are being tested in trial NCT05556954?

The interventions under investigation include: Wound debridement (PROCEDURE).

Who is sponsoring clinical trial NCT05556954?

This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.